Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model
Article first published online: 16 AUG 2012
© 2012 John Wiley & Sons Ltd
Influenza and Other Respiratory Viruses
Volume 7, Issue 4, pages 506–512, July 2013
How to Cite
Ducatez, M. F., Webb, A., Crumpton, J.-C. and Webby, R. J. (2013), Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model. Influenza and Other Respiratory Viruses, 7: 506–512. doi: 10.1111/j.1750-2659.2012.00423.x
- Issue published online: 11 JUN 2013
- Article first published online: 16 AUG 2012
- Accepted 30 June 2012. Published Online 16 August 2012.
- 3World Organization for Animal Health. Update on highly pathogenic avian influenza in animals (type H5 and H7). Available at http://www.oie.int/downld/AVIAN%20INFLUENZA/A_AI-Asia.htm (Accessed 6 February 2012).
- 4World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. 2011. Available at http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html (Accessed 6 February 2012).
- 5Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis2008; 14:e1., , et al.
- 6World Health Organization. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness – February 2011. Wkly Epidemiol Rec2011; 86:93–100.
- 10Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains. Influenza Other Respi Viruses2007; 1:199–206., , et al.
- 21World Health Organization. WHO manual on animal diagnosis and surveillance. 2011. Available at http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf (Accessed 21 October 2011).
- 22A simple method for estimating fifty percent endpoints. Am J Hyg1938; 27:493–497., .
- 25Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine2010; 28:849–857., , et al.
- 31Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respi Viruses2008; 2:115–125., , et al.